Dr. Goldberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology at the Byers Eye Institute at Stanford University. His clinical effort is focused on patients in need of medical or surgical intervention for glaucoma and other retinal and optic nerve diseases, as well as cataract. His research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, a major unmet need in glaucoma and other optic neuropathies, and his laboratory is developing novel stem cell and nanotherapeutics approaches for eye repair.
Dr. Goldberg received his B.S. magna cum laude from Yale University, and his M.D. and Ph.D. from Stanford University where he made significant discoveries about the failure of optic nerve regeneration. He did his clinical training in ophthalmology and then in glaucoma at the Bascom Palmer Eye Institute, and was awarded a fellowship from the Heed Foundation. He was named the 2010 Scientist of the Year by the Hope For Vision foundation, and received the Cogan award from the Association for Research in Vision and Ophthalmology in 2012. He was elected in 2010 to the American Society of Clinical Investigation, an honorary society of physician scientists. He directs an NIH-funded research laboratory and has developed significant expertise with implementing FDA IND clinical trials for optic nerve neuroprotection and regeneration. His goal is to translate scientific discoveries to patient therapies.
Education & Training
- University of Miami Hospital and ClinicsFellowship, Glaucoma, 2009 - 2010
- University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2005 - 2008
- Santa Clara Valley Medical CenterInternship, Transitional Year, 2003 - 2004
- Stanford University School of MedicineClass of 2003
- Yale UniversityBS, Biology, 1990 - 1994
Certifications & Licensure
- CA State Medical License 2012 - 2026
- FL State Medical License 2008 - 2014
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Member American Glaucoma Society
- Member Society for Neuroscience
- Elected Member The American Society for Clinical Investigation, 2011
- Join now to see all
Clinical Trials
- Steroids After Laser Trabeculoplasty for Glaucoma Start of enrollment: 2009 Sep 01
- NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement Start of enrollment: 2011 Apr 01
- NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- Development of a novel SupraChoroidal-to-Optic-NervE (SCONE) drug delivery system.Bryce Chiang, Kathleen Heng, Kyeongwoo Jang, Roopa Dalal, Yaping Joyce Liao
Drug Delivery. 2024-12-01 - 1 citationsBringing Eye Transplant Into the Light.Jeffrey L Goldberg
JAMA. 2024-11-12 - Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide.Ying Zhu, Ramesh V Nair, Xin Xia, Michael Nahmou, Xueyi Li
Experimental Eye Research. 2024-09-01
Journal Articles
- The Krüppel-like Factor Gene Target Dusp14 Regulates Axon Growth and RegenerationJeffrey L Goldberg, Akintomide Apara, Investigative Ophthalmology and Visual Science
Press Mentions
- UC San Diego and Scripps Research Join National Team to Make Vision-Restoring Whole Eye Transplants a RealityDecember 3rd, 2024
- UTSW Joins Project to Make Whole Eye Transplants a RealityDecember 3rd, 2024
- Emmecell Announces Advancements of Non-Surgical Cell Therapy for Corneal EdemaNovember 19th, 2024
- Join now to see all
Grant Support
- Signaling Scaffolds And Survival In StrokeNational Eye Institute2012
- Triazine-Based Compounds To Promote Regeneration In Optic NeuropathiesNational Institute Of Neurological Disorders And Stroke2011
- Kruppel-Like Transcription Factors In Retinal Ganglion Cell RegenerationNational Eye Institute2010–2011
- Retinal Scaffolds: Synaptic And Stem Cell IntegrationNational Eye Institute2009–2010
- Developmental Control Of Axon Regeneration In RgcsNational Institute Of Neurological Disorders And Stroke2007–2010
- Magnetic Nanoparticles For Trophic Stimulation And Axon RegenerationNational Eye Institute2007–2009
- Intrinsic Molecular Control Of Axon Regeneration In RgcsNational Eye Institute2005–2007
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: